drugset / Trial / NCT02406560

A Study Comparing The Amounts of Tafamidis In The Blood With Or Without Food

NCT02406560

Phase 1 Completed 12 enrolled Pfizer
RandomizedCrossoverOpen-labelBasic science

Summary

Each subject will be given tafamidis after either a high fat meal or while fasted. After swallowing tafamidis, tafamidis blood concentrations will be measured periodically for one week. After about 14 days, subjects will take either a different dose of tafamidis or the same dose under the opposite meal condition. Tafamidis concentrations from the three different conditions will be compared to determine if they are approximately the same.

Timeline

Start
2015-04
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Tafamidis Unknown 48.8 mg Oral
Subject Tafamidis Unknown 61 mg Oral

Indications

No indication recorded.